I armen med eptifibatid i undersøgelsen fik næsten alle patienter acetylsalicylsyre (99, 7%), og 98, 1% fik thienopyridin (clopidogrel hos 95, 4% og ticlopidin hos 2, 7%).
12 In the eptifibatide arm of the trial, virtually all patients received aspirin (99.7%), and 98.1% received a thienopyridine, (clopidogrel in 95.4% and ticlopidine in 2.7%).